CureVac NV
NASDAQ:CVAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CureVac NV
NASDAQ:CVAC
|
DE |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
BR |
|
S
|
Schroders PLC
XBER:PYX
|
UK |
|
L
|
Laurentian Bank of Canada
OTC:LRCDF
|
CA |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CVAC's stock price target?
Not Available
CVAC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for CureVac NV?
Projected CAGR
-22%
Over the last 5 years, the compound annual growth rate for Revenue has been 98%. The projected CAGR for the next 4 years is -22%.
What is the Operating Income forecast for CureVac NV?
Projected CAGR
-27%
The compound annual growth rate for Operating Income over the next 4 years is -27%.